Sofie Demeyer

2.3k citations

45 papers · 1.2k · h-index 19

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Public Health, Environmental and Occupational Health top 5%
- Acute Lymphoblastic Leukemia research

Papers in

Public Health, Environmental and Occupational Health 16
- Acute Lymphoblastic Leukemia research 16
Molecular Biology 14

Co-authors: Jan Cools (29 shared papers)Mario Pickavet (12 shared papers)Pieter Audenaert (11 shared papers)Charles E. de Bock (13 shared papers)Ellen Geerdens (10 shared papers)Didier Colle (6 shared papers)Olga Gielen (16 shared papers)Piet Demeester (5 shared papers)
Journals: Blood (8 papers)Haematologica (5 papers)Leukemia (4 papers)Journal of Hematology & Oncology (2 papers)PLoS ONE (2 papers)
Partner nations: Belgium United Kingdom United States

In The Last Decade

Sofie Demeyer

43 papers receiving 1.2k citations

Peers

Countries citing papers authored by Sofie Demeyer

Since Specialization

Citations

This map shows the geographic impact of Sofie Demeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Demeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Demeyer more than expected).

Fields of papers citing papers by Sofie Demeyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofie Demeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Demeyer. The network helps show where Sofie Demeyer may publish in the future.

Co-authors

The 25 scholars most cited alongside Sofie Demeyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sofie Demeyer Line = papers co-authored together Sofie Demeyer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Worldwide energy needs for ICT: The rise of power-aware networking Mario Pickavet, Willem Vereecken, Sofie Demeyer, Pieter Audenaert, Brecht Vermeulen, Chris Develder, Didier Colle, Bart Dhoedt, Piet Demeester	2008	216
2	Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia Haematologica ·Carmen Vicente, Claire Schwab, Michaël Broux, Ellen Geerdens, Sandrine Degryse, Sofie Demeyer, Idoya Lahortiga, Alfred M. Elliott, Lucy Chilton, Roberta La Starza, Cristina Mecucci, Peter Vandenberghe, Nicholas Goulden, Ajay Vora, Anthony V. Moorman, Jean Soulier, Christine J. Harrison, Emmanuelle Clappier, Jan Cools	2015	113
3	JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model Blood ·Sandrine Degryse, Charles E. de Bock, Luk Cox, Sofie Demeyer, Olga Gielen, Nicole Mentens, Kris Jacobs, Ellen Geerdens, Valentina Gianfelici, Gert Hulselmans, Mark Fiers, Stein Aerts, Jules P.P. Meijerink, Thomas Tousseyn, Jan Cools	2014	109
4	Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition Science Translational Medicine ·R. Habets, Charles E. de Bock, Lutgarde Serneels, Inge Lodewijckx, Delphine Verbeke, David Nittner, Rajeshwar Narlawar, Sofie Demeyer, James Dooley, Adrian Liston, Tom Taghon, Jan Cools, Bart De Strooper	2019	77
5	HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development Cancer Discovery ·Charles E. de Bock, Sofie Demeyer, Sandrine Degryse, Delphine Verbeke, Bram Sweron, Olga Gielen, Roel Vandepoel, Carmen Vicente, Marlies Vanden Bempt, Antonis Dagklis, Ellen Geerdens, Simon Bornschein, Rik Gijsbers, Jean Soulier, Jules P.P. Meijerink, (unknown), Susanna Teppo, Maria Bouvy‐Liivrand, Olli Lohi, Enrico Radaelli, Jan Cools	2018	70
6	Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia Leukemia ·Sandrine Degryse, Charles E. de Bock, Sofie Demeyer, Inge Govaerts, Simon Bornschein, Delphine Verbeke, Kris Jacobs, Steve Binos, David A. Skerrett‐Byrne, Heather C. Murray, Nicole M. Verrills, Pieter Van Vlierberghe, Jan Cools, Matthew D. Dun	2017	64
7	Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia Leukemia ·Jolien De Bie, Sofie Demeyer, Llucia Albertí Servera, Ellen Geerdens, Heidi Segers, Michaël Broux, Kim De Keersmaecker, Lucienne Michaux, Peter Vandenberghe, Thierry Voet, Nancy Boeckx, Anne Uyttebroeck, Jan Cools	2018	63
8	Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia Blood ·Llucia Albertí Servera, Sofie Demeyer, Inge Govaerts, Toon Swings, Jolien De Bie, Olga Gielen, Marco Brociner, Lucienne Michaux, Johan Maertens, Anne Uyttebroeck, Kim De Keersmaecker, Nancy Boeckx, Heidi Segers, Jan Cools	2020	47
9	Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia Cancer Cell ·Marlies Vanden Bempt, Sofie Demeyer, Michaël Broux, Jolien De Bie, Simon Bornschein, Nicole Mentens, Roel Vandepoel, Ellen Geerdens, Enrico Radaelli, Beat Bornhäuser, Andreas E. Kulozik, Jules P.P. Meijerink, Jean‐Pierre Bourquin, Charles E. de Bock, Jan Cools	2018	42
10	Hedgehog pathway activation in T-cell acute lymphoblastic leukemia predicts response to SMO and GLI1 inhibitors Blood ·Antonis Dagklis, Sofie Demeyer, Jolien De Bie, Enrico Radaelli, Daphnie Pauwels, Sandrine Degryse, Olga Gielen, Carmen Vicente, Roel Vandepoel, Ellen Geerdens, Anne Uyttebroeck, Nancy Boeckx, Charles E. de Bock, Jan Cools	2016	40
11	The Long Non-coding RNA Flatr Anticipates Foxp3 Expression in Regulatory T Cells Frontiers in Immunology ·Aleksandra Brajic, Dean Franckaert, Oliver T. Burton, Simon Bornschein, A. Calvanese, Sofie Demeyer, Jan Cools, James Dooley, Susan Schlenner, Adrian Liston	2018	38
12	Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia Blood ·Michaël Broux, Cristina Prieto, Sofie Demeyer, Marlies Vanden Bempt, Llucia Albertí Servera, Inge Lodewijckx, Roel Vandepoel, Nicole Mentens, Olga Gielen, Kris Jacobs, Ellen Geerdens, Carmen Vicente, Charles E. de Bock, Jan Cools	2019	33
13	Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL Blood ·Sandrine Degryse, Simon Bornschein, Charles E. de Bock, Emilie Leroy, Marlies Vanden Bempt, Sofie Demeyer, Kris Jacobs, Ellen Geerdens, Olga Gielen, Jean Soulier, Christine J. Harrison, Stefan N. Constantinescu, Jan Cools	2017	30
14	Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma Blood ·Ana Silva, Afonso R. M. Almeida, Ana Cachucho, João Luís Neto, Sofie Demeyer, Mafalda Matos, Thea Hogan, Yunlei Li, Jules P.P. Meijerink, Jan Cools, Ana Rita Grosso, Benedict Seddon, João T. Barata	2021	28
15	Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system Leukemia ·Simon Bornschein, Sofie Demeyer, Rocco Stirparo, Olga Gielen, Carmen Vicente, Ellen Geerdens, Bart Ghesquière, Stein Aerts, Jan Cools, Charles E. de Bock	2017	23
16	Speeding up Martins’ algorithm for multiple objective shortest path problems 4OR ·Sofie Demeyer, Jan Goedgebeur, Pieter Audenaert, Mario Pickavet, Piet Demeester	2013	23
17	The Index-Based Subgraph Matching Algorithm with General Symmetries (ISMAGS): Exploiting Symmetry for Faster Subgraph Enumeration PLoS ONE ·Maarten Houbraken, Sofie Demeyer, Tom Michoel, Pieter Audenaert, Didier Colle, Mario Pickavet	2014	22
18	The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia Clinical Cancer Research ·Delphine Verbeke, Sofie Demeyer, Cristina Prieto, Charles E. de Bock, Jolien De Bie, Olga Gielen, Kris Jacobs, Nicole Mentens, Bronte Manouk Verhoeven, Anne Uyttebroeck, Nancy Boeckx, Kim De Keersmaecker, Johan Maertens, Heidi Segers, Jan Cools	2020	21
19	Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified Nature Communications ·Koen Debackere, Lukas Marcelis, Sofie Demeyer, Marlies Vanden Bempt, Nicole Mentens, Olga Gielen, Kris Jacobs, Michaël Broux, Gregor Verhoef, Lucienne Michaux, Carlos Graux, Iwona Włodarska, Philippe Gaulard, Laurence de Leval, Thomas Tousseyn, Jan Cools, Daan Dierickx	2021	18
20	The Index-Based Subgraph Matching Algorithm (ISMA): Fast Subgraph Enumeration in Large Networks Using Optimized Search Trees PLoS ONE ·Sofie Demeyer, Tom Michoel, Jan Fostier, Pieter Audenaert, Mario Pickavet, Piet Demeester	2013	16

About Sofie Demeyer

Sofie Demeyer is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology, Hematology, Immunology and Oncology, having authored 45 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (16 papers), Acute Myeloid Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (7 papers), Data Management and Algorithms (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (4 papers), Transportation Planning and Optimization (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (320 citations), Public Health, Environmental and Occupational Health (332 citations), Genetics (106 citations), Cancer Research (145 citations) and Immunology (186 citations). Sofie Demeyer has collaborated with scholars based in Belgium, United Kingdom and United States. Frequent co-authors include Jan Cools, Mario Pickavet, Pieter Audenaert, Charles E. de Bock, Ellen Geerdens, Didier Colle, Olga Gielen, Piet Demeester, Sandrine Degryse and Willem Vereecken. Their work appears in journals such as Blood, Haematologica, Leukemia, Journal of Hematology & Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Sofie Demeyer

Impact in

Papers in i

In The Last Decade

Sofie Demeyer

Peers

Countries citing papers authored by Sofie Demeyer

Fields of papers citing papers by Sofie Demeyer

All Works

About Sofie Demeyer

Explore authors with similar magnitude of impact

Papers in